(VIANEWS) – REACH SUBSEA (REACH.OL), NEOEN (NEOEN.PA), MONTEA (MONT.BR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. REACH SUBSEA (REACH.OL)
96.2% sales growth and 26.05% return on equity
Reach Subsea ASA provides subsea services in Norway and internationally. It operates in two segments, Oil & Gas and Renewable/Other. The company offers inspection, maintenance, and repair services, such as structural inspections, WROV operation, SCM changeout, scale squeeze operations, water injection, ready for operation, subsea equipment maintenance, repair, commissioning, and boulder clearance; and construction support services, including seabed intervention, boulder clearance, touchdown monitoring, and pre-lay and post- lay survey, as well as vessel, remotely operated vehicles, personnel, survey, and on demand engineering. It also provides asset integrity/pipeline inspection, and engineering and project management services; reach remote services comprising survey, inspection, and IMR and seabed intervention; seabed survey services consisting of site surveys and geohazard investigation, pipeline inspection, seabed mapping, UXO, general, and route surveys; offshore cable; marine construction; and rig and mooring services. In addition, the company offers geophysical monitoring services, which include 4D gravity, seafloor subsidence monitoring, depth watch for seismic nodes, injection integrity monitoring, well drilling, and real time seismic monitoring services; and environmental monitoring services that comprise earthquake monitoring and prediction, C02 storage, and geothermal energy exploitation. It serves oil and gas, renewables, and utilities sectors. The company was formerly known as Transit Invest ASA and changed its name to Reach Subsea ASA in December 2012. Reach Subsea ASA was incorporated in 1909 and is headquartered in Haugesund, Norway.
Earnings Per Share
As for profitability, REACH SUBSEA has a trailing twelve months EPS of kr0.63.
PE Ratio
REACH SUBSEA has a trailing twelve months price to earnings ratio of 7. Meaning, the purchaser of the share is investing kr7 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.05%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 78.2%, now sitting on 1.85B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 113% and a drop 122.2% for the next.
Sales Growth
REACH SUBSEA’s sales growth is 27.4% for the ongoing quarter and 96.2% for the next.
Yearly Top and Bottom Value
REACH SUBSEA’s stock is valued at kr4.41 at 16:20 EST, way under its 52-week high of kr5.22 and way above its 52-week low of kr3.54.
More news about REACH SUBSEA.
2. NEOEN (NEOEN.PA)
48.5% sales growth and 7.39% return on equity
Neoen S.A., an independent renewable energy production company, engages in the development and operation of renewable energy power plants. The company operates through Solar Power, Wind Power, Storage, Farm-Down, Development and Investments, and Eliminations segments. It operates in Argentina, Australia, Canada, Ecuador, the United States, Finland, France, Ireland, Italy, Jamaica, Mexico, Mozambique, Portugal, El Salvador, Sweden, and Zambia. Neoen S.A. was incorporated in 2008 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, NEOEN has a trailing twelve months EPS of €1.13.
PE Ratio
NEOEN has a trailing twelve months price to earnings ratio of 21.52. Meaning, the purchaser of the share is investing €21.52 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.39%.
More news about NEOEN.
3. MONTEA (MONT.BR)
25.8% sales growth and 5.79% return on equity
Earnings Per Share
As for profitability, MONTEA has a trailing twelve months EPS of €3.82.
PE Ratio
MONTEA has a trailing twelve months price to earnings ratio of 19.9. Meaning, the purchaser of the share is investing €19.9 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.79%.
More news about MONTEA.
4. X-FAB (XFAB.PA)
23.3% sales growth and 19.58% return on equity
X-FAB Silicon Foundries SE operates as an analog/mixed-signal semiconductor technology foundry. The company manufactures silicon wafers for automotive, industrial, consumer, medical, and mobile communications, and other applications; and analog/mixed-signal integrated circuits, sensors, and micro-electro-mechanical systems. It also provides manufacturing and design support services for customers that design analog/mixed-signal integrated circuits and other semiconductor devices, as well as engineering and prototyping, outsourcing, technical, and design support services. The company serves integrated device manufacturers, original equipment manufacturers, and fabless semiconductor companies. It operates in Belgium, Germany, the United Kingdom, Austria, France, Switzerland, Denmark, Sweden, Finland, Netherlands, Ireland, Singapore, China, Japan, Thailand, Malaysia, Korea, Taiwan, Hong Kong, New Zealand, the United States, and internationally. The company was founded in 1992 and is based in Tessenderlo, Belgium.
Earnings Per Share
As for profitability, X-FAB has a trailing twelve months EPS of €1.16.
PE Ratio
X-FAB has a trailing twelve months price to earnings ratio of 6.51. Meaning, the purchaser of the share is investing €6.51 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.58%.
Moving Average
X-FAB’s value is way under its 50-day moving average of €9.74 and way under its 200-day moving average of €9.14.
Revenue Growth
Year-on-year quarterly revenue growth grew by 24.1%, now sitting on 852.69M for the twelve trailing months.
Volume
Today’s last reported volume for X-FAB is 1186150 which is 1188.81% above its average volume of 92034.
Yearly Top and Bottom Value
X-FAB’s stock is valued at €7.55 at 16:20 EST, way below its 52-week high of €11.62 and way higher than its 52-week low of €5.21.
More news about X-FAB.
5. NAVAMEDIC (NAVA.OL)
20.7% sales growth and 11.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.18.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 32.2. Meaning, the purchaser of the share is investing kr32.2 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.97%.
Volume
Today’s last reported volume for NAVAMEDIC is 3422 which is 66.65% below its average volume of 10262.
Moving Average
NAVAMEDIC’s worth is above its 50-day moving average of kr37.62 and higher than its 200-day moving average of kr37.33.
Revenue Growth
Year-on-year quarterly revenue growth grew by 51.9%, now sitting on 502.65M for the twelve trailing months.
Sales Growth
NAVAMEDIC’s sales growth is 19% for the current quarter and 20.7% for the next.
More news about NAVAMEDIC.
6. SATS (SATS.OL)
10.1% sales growth and 3.89% return on equity
Sats ASA provides fitness and training services in Norway, Sweden, Denmark, and Finland. The company offers sportswear, fitness gear, bars, and energy drinks. It operates 275 fitness clubs under the SATS, ELIXIA, Fresh Fitness, SATSonline and SATSYoga brands. The company was founded in 1995 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, SATS has a trailing twelve months EPS of kr0.17.
PE Ratio
SATS has a trailing twelve months price to earnings ratio of 105.65. Meaning, the purchaser of the share is investing kr105.65 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.89%.
Sales Growth
SATS’s sales growth is 9.4% for the current quarter and 10.1% for the next.
Yearly Top and Bottom Value
SATS’s stock is valued at kr17.96 at 16:20 EST, below its 52-week high of kr19.30 and way above its 52-week low of kr6.30.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.4%, now sitting on 4.59B for the twelve trailing months.
More news about SATS.
7. SEABIRD EXPLORAT (SBX.OL)
7.1% sales growth and 21.51% return on equity
SeaBird Exploration Plc, together with its subsidiaries, provides marine 2D and 3D seismic data for the oil and gas industry in Europe, Africa, the Middle East, North and South America, and the Asia Pacific. It offers 2D seismic; and source vessels that provide conventional undershoot, 4D repeat survey, wide azimuth, push reverse, long-term charter and vessel management, in-house source modelling and environmental decay analysis, and spot charter services. The company was founded in 1996 and is based in Nicosia, Cyprus.
Earnings Per Share
As for profitability, SEABIRD EXPLORAT has a trailing twelve months EPS of kr0.32.
PE Ratio
SEABIRD EXPLORAT has a trailing twelve months price to earnings ratio of 14.11. Meaning, the purchaser of the share is investing kr14.11 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.51%.
Volume
Today’s last reported volume for SEABIRD EXPLORAT is 58082 which is 63.19% below its average volume of 157799.
Yearly Top and Bottom Value
SEABIRD EXPLORAT’s stock is valued at kr4.52 at 16:20 EST, way below its 52-week high of kr6.00 and way above its 52-week low of kr3.40.
More news about SEABIRD EXPLORAT.
